---
title: "Kalaris and AlloVir merger approved by stockholders; combined company to trade under \"KLRS\" on Nasdaq."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231589020.md"
description: "The merged company is anticipated to debut on the Nasdaq stock exchange under the ticker symbol \"KLRS\" following the completion of the merger."
datetime: "2025-03-12T20:22:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231589020.md)
  - [en](https://longbridge.com/en/news/231589020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231589020.md)
generator: "portal-rs"
---

# Kalaris and AlloVir merger approved by stockholders; combined company to trade under "KLRS" on Nasdaq.

The merged company is anticipated to debut on the Nasdaq stock exchange under the ticker symbol "KLRS" following the completion of the merger.

### Related Stocks

- [ALVR.US](https://longbridge.com/en/quote/ALVR.US.md)

## Related News & Research

- [Nasdaq Helsinki fines Summa Defence EUR 200,000 for First North rule breaches](https://longbridge.com/en/news/297767526.md)
- [Nasdaq completes acquisition of AI due diligence platform Dasseti](https://longbridge.com/en/news/297782568.md)
- [Conexeu Sciences to present at Nasdaq/LD Micro Summit Series](https://longbridge.com/en/news/297653168.md)
- [Calamos Alternative Nasdaq & Bond ETF declares $0.1109 dividend](https://longbridge.com/en/news/297736994.md)
- [BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) | BHST Stock News](https://longbridge.com/en/news/297905663.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**